{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:27:54Z","timestamp":1648704474020},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,9,28]],"date-time":"2013-09-28T00:00:00Z","timestamp":1380326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s12664-013-0407-1","type":"journal-article","created":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T21:56:57Z","timestamp":1380232617000},"page":"141-145","source":"Crossref","is-referenced-by-count":2,"title":["Human immunodeficiency virus and hepatitis C virus coinfection in Nepal"],"prefix":"10.1007","volume":"33","author":[{"given":"Satish Prasad","family":"Barnawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surya Raj","family":"Niraula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand Kumar","family":"Agrahari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikesh","family":"Bista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilambar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paras Kumar","family":"Pokharel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,28]]},"reference":[{"key":"407_CR1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4254\/wjh.v2.i1.42","volume":"2","author":"GK Anbazhagan","year":"2010","unstructured":"Anbazhagan GK, Krishnamoorthy S, Thiyagarajan T. Seroprevalence of HCV and its co-infection with HBV and HIV among liver disease patients of South Tamil Nadu. World J Hepatol. 2010;2:42\u20138.","journal-title":"World J Hepatol"},{"key":"407_CR2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00002030-200204120-00001","volume":"16","author":"V Soriano","year":"2002","unstructured":"Soriano V, Sulkowski M, Bergin C, et al. Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV\u00b1HCV International Panel. AIDS. 2002;16:813\u201328.","journal-title":"AIDS"},{"key":"407_CR3","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1097\/01.aids.0000192088.72055.90","volume":"19","author":"SH Mehta","year":"2005","unstructured":"Mehta SH, Thomas DL, Sulkowski MS, et al. A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV\/HCV-co-infected injection drug users. AIDS. 2005;19:S179\u201389.","journal-title":"AIDS"},{"key":"407_CR4","unstructured":"Annual Report, Department of Health Services. Government of Nepal, Ministry of Health and Population, Department of Health Services, Kathmandu. 2009\/2010:4."},{"key":"407_CR5","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3201\/eid1309.070036","volume":"13","author":"CS Todd","year":"2007","unstructured":"Todd CS, Abed AMS, Strathdee SA, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis. 2007;13:1327\u201331.","journal-title":"Emerg Infect Dis"},{"key":"407_CR6","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/01.aids.0000233577.33973.fa","volume":"20","author":"HZ Qian","year":"2006","unstructured":"Qian HZ, Vermund SH, Kaslow RA, et al. Co-infection with HIV and hepatitis C virus in former plasma\/blood donors: challenge for patient care in rural China. AIDS. 2006;20:1429\u201335.","journal-title":"AIDS"},{"key":"407_CR7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00002030-200405210-00010","volume":"18","author":"WP Law","year":"2004","unstructured":"Law WP, Duncombe CJ, Mahanontharit A, et al. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS. 2004;18:1169\u201377.","journal-title":"AIDS"},{"key":"407_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1758-2652-14-22","volume":"14","author":"DL Thomas","year":"2011","unstructured":"Thomas DL, Leoutsakas D, Zabransky T, Kumar MS. Hepatitis C in HIV-infected individuals: cure and control, right now. J Int AIDS Soc. 2011;14:22\u20139.","journal-title":"J Int AIDS Soc"},{"key":"407_CR9","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/QAD.0b013e328330ed24","volume":"23","author":"A Schnuriger","year":"2009","unstructured":"Schnuriger A, Dominguez S, Guiguet M, et al. Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus. AIDS. 2009;23:2079\u201389.","journal-title":"AIDS"},{"key":"407_CR10","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/01.aids.0000226958.87471.48","volume":"20","author":"PS Sullivan","year":"2006","unstructured":"Sullivan PS, Hanson DL, Teshale EH, et al. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. AIDS. 2006;20:1171\u20139.","journal-title":"AIDS"},{"key":"407_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-200401020-00001","volume":"18","author":"V Soriano","year":"2004","unstructured":"Soriano V, Puoti M, Sulkowski M, et al. Care of patients with hepatitis C and HIV co-infection. AIDS. 2004;18:1\u201312.","journal-title":"AIDS"},{"key":"407_CR12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/QAI.0b013e3181b67527","volume":"53","author":"PR Spradling","year":"2010","unstructured":"Spradling PR, Richardson JT, Buchacz K, et al. Trends in hepatitis C virus infection among patients in the HIV outpatient study, 1996\u20132007. J Acquir Immune Defic Syndr. 2010;53:388\u201396.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"407_CR13","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1097\/QAD.0b013e32833dba03","volume":"24","author":"H Hatano","year":"2010","unstructured":"Hatano H, Delwart EL, Norris PJ, et al. Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals. AIDS. 2010;24:2535\u20139.","journal-title":"AIDS"},{"key":"407_CR14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.qai.0000165911.97085.d0","volume":"40","author":"A Sighem","year":"2005","unstructured":"Sighem A, Danner S, Ghani AC, et al. Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non\u2013HIV-infected individuals. J Acquir Immune Defic Syndr. 2005;40:212\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"407_CR15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/QAI.0b013e318198a0e1","volume":"50","author":"L Peters","year":"2009","unstructured":"Peters L, Mocroft A, Soriano V, et al. Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1\u2013infected patients with maximum virologic suppression. J Acquir Immune Defic Syndr. 2009;50:457\u201363.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"407_CR16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00126334-200210010-00005","volume":"31","author":"SL George","year":"2002","unstructured":"George SL, Gebhardt J, Klinzman D, et al. Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests. J Acquir Immune Defic Syndr. 2002;31:154\u201362.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"407_CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1590\/S1413-86702010000200004","volume":"14","author":"MB Victoria","year":"2010","unstructured":"Victoria MB, Victoria FS, Torres KL, et al. Epidemiology of HIV\/HCV coinfection in patients cared for at the Tropical Medicine Foundation of Amazonas. Braz J Infect Dis. 2010;14:135\u20139.","journal-title":"Braz J Infect Dis"},{"key":"407_CR18","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1097\/01.aids.0000192090.61753.d4","volume":"19","author":"H Hagan","year":"2005","unstructured":"Hagan H, Thiede H, Jarlais DCD. HIV\/hepatitis C virus co-infection in drug users: risk behavior and prevention. AIDS. 2005;19:S199\u2013207.","journal-title":"AIDS"},{"key":"407_CR19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1743-422X-7-230","volume":"7","author":"M Jobarteh","year":"2010","unstructured":"Jobarteh M, Malfroy M, Peterson I, et al. Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians. Virol J. 2010;7:230\u201340.","journal-title":"Virol J"},{"key":"407_CR20","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1097\/QAD.0b013e3282f10de9","volume":"21","author":"MS Sulkowski","year":"2007","unstructured":"Sulkowski MS, Mehta SH, Torbenson MS, et al. Rapid fibrosis progression among HIV\/hepatitis C virus-co-infected adults. AIDS. 2007;21:2209\u201316.","journal-title":"AIDS"},{"key":"407_CR21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/QAI.0b013e31803151c7","volume":"44","author":"SD Shafran","year":"2007","unstructured":"Shafran SD. Early Initiation of antiretroviral therapy: the current best way to reduce liver-related deaths in HIV\/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr. 2007;44:551\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"407_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.qai.0000191281.77954.27","volume":"41","author":"A Luetkemeyer","year":"2006","unstructured":"Luetkemeyer A, Hare CB, Stansell J, et al. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr. 2006;41:31\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"407_CR23","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1097\/QAD.0b013e32833adbb5","volume":"24","author":"M Potter","year":"2010","unstructured":"Potter M, Odueyungbo A, Yang H, et al. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV\u2013HCV coinfection before and after antiretroviral therapy. AIDS. 2010;24:1857\u201365.","journal-title":"AIDS"},{"key":"407_CR24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/QAI.0b013e31804d685b","volume":"45","author":"L Gras","year":"2007","unstructured":"Gras L, Kesselring AM, Griffin JT, et al. CD4 cell counts of 800 cells\/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells\/mm3 or greater. J Acquir Immune Defic Syndr. 2007;45:183\u201392.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"407_CR25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.aids.0000198091.70325.f4","volume":"20","author":"P Braitstein","year":"2006","unstructured":"Braitstein P, Justice A, Bangsberg DR, et al. Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS. 2006;20:323\u201331.","journal-title":"AIDS"},{"key":"407_CR26","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1097\/00002030-200411190-00002","volume":"18","author":"P Braitstein","year":"2004","unstructured":"Braitstein P, Palepu A, Dieterich D, et al. Special considerations in the initiation and management of antiretroviral therapy in individuals co-infected with HIV and hepatitis C. AIDS. 2004;18:2221\u201334.","journal-title":"AIDS"},{"key":"407_CR27","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.aids.0000192065.09281.01","volume":"19","author":"LI Backus","year":"2005","unstructured":"Backus LI, Boothroyd D, Deyton LR. HIV, hepatitis C and HIV\/hepatitis C virus co-infection in vulnerable populations. AIDS. 2005;19:S13\u20139.","journal-title":"AIDS"},{"key":"407_CR28","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/01.aids.0000186824.53359.62","volume":"19","author":"JL Richardson","year":"2005","unstructured":"Richardson JL, Nowicki M, Danley K, et al. Neuropsychological functioning in a cohort of HIV and hepatitis C virus-infected women. AIDS. 2005;19:1659\u201367.","journal-title":"AIDS"},{"key":"407_CR29","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/01.aids.0000192067.94033.aa","volume":"19","author":"SD Rosenberg","year":"2005","unstructured":"Rosenberg SD, Drake RE, Brunette MF, et al. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. AIDS. 2005;19:S26\u201333.","journal-title":"AIDS"},{"key":"407_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2334-10-53","volume":"10","author":"S Gupta","year":"2010","unstructured":"Gupta S, Singh S. Occult hepatitis B virus infection in ART-na\u00efve HIV-infected patients seen at a tertiary care centre in north India. BMC Infect Dis. 2010;10:53\u20139.","journal-title":"BMC Infect Dis"},{"key":"407_CR31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijid.2007.04.015","volume":"12","author":"MH Kuniholm","year":"2008","unstructured":"Kuniholm MH, Mark J, Aladashvili M, et al. Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients. Int J Infect Dis. 2008;12:51\u20136.","journal-title":"Int J Infect Dis"},{"key":"407_CR32","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1097\/QAD.0b013e32801086da","volume":"20","author":"SH Mehta","year":"2006","unstructured":"Mehta SH, Lucas GM, Mirel LB, et al. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS. 2006;20:2361\u20139.","journal-title":"AIDS"},{"key":"407_CR33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.aids.0000198087.47454.e1","volume":"20","author":"N Merchante","year":"2006","unstructured":"Merchante N, Giro'n-Gonza'lez JA, Serrano MG, et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS. 2006;20:49\u201357.","journal-title":"AIDS"},{"key":"407_CR34","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/QAI.0b013e3181f9c0c9","volume":"55","author":"C Beyrer","year":"2010","unstructured":"Beyrer C, Wirtz AL, Baral S, et al. Epidemiologic links between drug use and HIV epidemics: an international perspective. J Acquir Immune Defic Syndr. 2010;55:S10\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"407_CR35","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/QAD.0b013e32823f9066","volume":"21","author":"RS Garfein","year":"2007","unstructured":"Garfein RS, Golub ET, Greenberg AE, et al. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS. 2007;21:1923\u201332.","journal-title":"AIDS"},{"key":"407_CR36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.drugalcdep.2007.01.003","volume":"89","author":"A Neaigus","year":"2007","unstructured":"Neaigus A, Gyarmathy VA, Miller M, et al. Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend. 2007;89:234\u201343.","journal-title":"Drug Alcohol Depend"},{"key":"407_CR37","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2105\/AJPH.85.11.1531","volume":"85","author":"H Hagan","year":"1995","unstructured":"Hagan H, Jarlais DCD, Friedman SR, et al. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma Syringe Exchange Program. Am J Public Health. 1995;85:1531\u20137.","journal-title":"Am J Public Health"},{"key":"407_CR38","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1097\/01.aids.0000192086.64432.e7","volume":"19","author":"N Kontorinis","year":"2005","unstructured":"Kontorinis N, Agarwal K, Dieterich DT. Treatment of hepatitis C virus in HIV patients: a review. AIDS. 2005;19:S166\u201373.","journal-title":"AIDS"},{"key":"407_CR39","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/QAI.0b013e318068d190","volume":"45","author":"BH McGovern","year":"2007","unstructured":"McGovern BH. Hepatitis C, in the HIV-infected patient. J Acquir Immune Defic Syndr. 2007;45:S47\u201356.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-013-0407-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-013-0407-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-013-0407-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T21:49:15Z","timestamp":1564091355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-013-0407-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,28]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["407"],"URL":"https:\/\/doi.org\/10.1007\/s12664-013-0407-1","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,28]]}}}